[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Percutaneous Coronary Intervention Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 241 pages | ID: P72CA057030EN
VPAResearch

US$ 630.00 US$ 700.00 -10 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Percutaneous Coronary Intervention ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Percutaneous Coronary Intervention disease clinical trials. The research work analyzes the ongoing Percutaneous Coronary Intervention clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Percutaneous Coronary Intervention treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Percutaneous Coronary Intervention clinical trials.

Scope of the Report-
  • Ongoing Percutaneous Coronary Intervention clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Percutaneous Coronary Intervention
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Percutaneous Coronary Intervention clinical trials
Reasons to Buy
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Percutaneous Coronary Intervention Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Percutaneous Coronary Intervention Trials by Phase
3.2 Ongoing Percutaneous Coronary Intervention Trials by Type
3.3 Ongoing Percutaneous Coronary Intervention Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Percutaneous Coronary Intervention Trials
4.2 Top 10 Countries conducting Percutaneous Coronary Intervention Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Percutaneous Coronary Intervention Trials by Sponsor Type
5.2 Percutaneous Coronary Intervention Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Percutaneous Coronary Intervention Trials by year
6.2 Subjects Recruited for Percutaneous Coronary Intervention Trials by Phase
6.3 Subjects Recruited for Percutaneous Coronary Intervention Trials by Trial Type
6.4 Subjects Recruited for Percutaneous Coronary Intervention Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Percutaneous Coronary Intervention Trials- Phase
7.2 Ongoing Percutaneous Coronary Intervention Trials- Phase
7.3 Ongoing Percutaneous Coronary Intervention Trials- Phase
7.4 Ongoing Percutaneous Coronary Intervention Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

LIST OF FIGURES

Figure 1: Percutaneous Coronary Intervention- Clinical Trials by Country
Figure 2: Percutaneous Coronary Intervention- Clinical Trials by Phase of Development, 2018
Figure 3: Percutaneous Coronary Intervention- Clinical Trials by Status, 2018
Figure 4: Percutaneous Coronary Intervention- Clinical Trials by Type, 2018
Figure 5: Percutaneous Coronary Intervention- Clinical Trials Split by Region, 2000-2018
Figure 6: Percutaneous Coronary Intervention- Clinical Trials by Type of Economy, 2018
Figure 7: Percutaneous Coronary Intervention- Enrolment by Phase, 2018
Figure 8: Percutaneous Coronary Intervention- Enrolment by Trial Type, 2018
Figure 9: Percutaneous Coronary Intervention- Enrolment by Recruitment Status, 2018
Figure 10: Percutaneous Coronary Intervention- Clinical Trials by Sponsor Type, 2018
Figure 11: Percutaneous Coronary Intervention- Enrolment by Type of Sponsors
Figure 12: Percutaneous Coronary Intervention- Enrolment by Leading Sponsors

LIST OF TABLES

Table 1: Percutaneous Coronary Intervention- Clinical Trials by Sponsor Type, 2018
Table 2: Percutaneous Coronary Intervention- Clinical Trials by Economy Type, 2018
Table 3: Percutaneous Coronary Intervention- Clinical Trials by Region, 2018
Table 4: Percutaneous Coronary Intervention- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Percutaneous Coronary Intervention- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Percutaneous Coronary Intervention- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Percutaneous Coronary Intervention- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Percutaneous Coronary Intervention- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Percutaneous Coronary Intervention- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company


More Publications